Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety and Efficacy of Topamax Versus Carbamazepine in Benign Rolandic Epilepsy
This study has been completed.
Study NCT00216567   Information provided by Janssen Korea, Ltd., Korea
First Received: September 13, 2005   Last Updated: October 19, 2007   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Epilepsy, Rolandic
Additional conditions recognized in this trial
Epilepsy
More general conditions related to this trial
Brain Diseases
Central Nervous System Diseases
Epilepsies, Partial
Nervous System Diseases
Interventions listed in this trial
topamax
Additional drug interventions recognized in this trial
Carbamazepine
Topiramate
More general drug interventions related to this trial
Analgesics
Analgesics, Non-Narcotic
Anti-Obesity Agents
Anticonvulsants
Antimanic Agents
Central Nervous System Agents
Central Nervous System Depressants
Neuroprotective Agents
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Protective Agents
Psychotropic Drugs
Sensory System Agents
Therapeutic Uses
Tranquilizing Agents
Sponsors listed in this trial
Janssen Korea, Ltd., Korea


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services